Oseltamivir Dosing and Administration for a 7‑Year‑Old Child (≈23 kg)

Treatment Dosing (Active Influenza)

The American Academy of Pediatrics (AAP) recommends a dose of 45 mg oseltamivir twice daily for 5 days in children weighing 16–23 kg (≈34–51 lb) with confirmed or suspected influenza. 1
When using the 6 mg/mL oral suspension, the required volume is 7.5 mL administered twice daily to deliver the 45 mg dose. 1
If the child can swallow capsules, a single 45‑mg capsule may be given twice daily as an alternative formulation. 1
For a complete 5‑day treatment course, two bottles of the oral suspension should be dispensed to ensure sufficient supply. 1

The AAP advises 45 mg oseltamivir once daily for children in the same weight range when used for post‑exposure prophylaxis. 1
The corresponding oral suspension volume is 7.5 mL once daily. 1
Prophylaxis should be continued for 7 days after the last known exposure to the influenza virus, reflecting the 2024 AAP update that shortened the previous 10‑day recommendation. [1][2]3

Treatment must be initiated within 48 hours of symptom onset to achieve maximal antiviral efficacy. [2][3]
Prophylaxis should start within 48 hours of exposure to the virus to be effective. [2][3]

The most common adverse events in pediatric trials are nausea (43% higher than placebo) and vomiting (83% higher than placebo); both are generally mild and transient. 2
Discontinuation of therapy due to adverse events is rare, occurring in approximately 1.8% of pediatric participants in clinical studies. 2

For children with normal renal function, no dose adjustment is required; renal dosing tables are applicable only to children weighing >40 kg who qualify for adult dosing. 1

The AAP recommends starting oseltamivir without waiting for laboratory confirmation when influenza is clinically suspected during flu season, especially in children with risk factors (e.g., asthma, diabetes). [1][2]